Arthritis Therapeutics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027

Dec 2019| FMR559A| Fact Market Research

Report Highlights

Arthritis Therapeutics Market - Scope of the Study

Fact.MR, in its exclusive research report on the arthritis therapeutics market, highlights actionable insights and winning imperatives for stakeholders. This comprehensive study unfolds rare and distinguished intelligence regarding impactful dynamics, which directly or indirectly influence the growth of the arthritis therapeutics market during the forecast period (2020 - 2027). With the help of crucial insights discussed in this study, stakeholders will gain a thorough idea regarding the growth trajectory of the arthritis therapeutics market.

This comprehensive study offers incisive data regarding the drivers, threats, restraints, and opportunities present in the arthritis therapeutics market. The study also recalibrates the impact of each of these dynamics to estimate the size of the arthritis therapeutics market for the given period. Authors of the report have taken ample care to measure and include the relevance and impact of microeconomic as well as macroeconomic factors that hold potential to influence the growth of the arthritis therapeutics market during the forecast period.

The global study offers crucial information about global, regional, and local players operating in the arthritis therapeutics market, along with their estimated market share. Market share has been estimated in terms of value (US$ Mn). Besides providing key information regarding the concentration of leading, prominent, and local players, the study also aims at equipping stakeholders with the best of information regarding winning strategies, recent developments, and financials.

This detailed guide, based on the latest market movement, ensures that only precise information reaches stakeholders, so as to help them gain an upper hand over their competitors in the global arthritis therapeutics market. This exclusive guide offers crucial information about the current trends, pipeline drugs, unmet drugs, future scope, and government regulations for the arthritis therapeutics market.

Key players profiled in this comprehensive study on the arthritis therapeutics market include Sanofi, Novartis AG, F.Hoffmann-La Roche Ltd, Eli Lily and Company, Janssen Global Services, LLC, Amgen, Inc., AbbVie, Inc., Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, and Merck & Co., Inc.

Arthritis Therapeutics Market - Research Methodology

The research undertaken by seasoned analysts at Fact.MR consists of a systematic approach. A combination of the bottom-up and top-down approach is leveraged to estimate the size of the arthritis therapeutics market. Besides this, primary and secondary researches are carried out through credible sources to gain crucial insights into the arthritis therapeutics market. For conducting primary research, interviews and discussions were carried out with industry experts, key opinion leaders, vendors, and distributors.

Besides these, respondents also include CEOs, presidents, directors, chairmen, vice presidents, marketing managers, suppliers, distributors, and chief medical officers, among others. This helps in assessing the demand-supply gap prevailing in the arthritis therapeutics market. In order to conduct secondary research, marketing collaterals, company websites, industry associations, and government statistics were studied. In addition to this, reports as well as content pieces published by credible sources, such as company annual reports, investor presentations, and SEC-filings were studied.

Besides this, governmental and public portals, such as World Health Organization (WHO), OECD, FDA, Centres of Disease Control and Prevention (CDC), the Centres for Medicare & Medicaid Services, MoHFW, Government of India, Dermatology News, Arthritis Foundation, National Psoriasis Foundation, Arthritis Foundation, Psoriasis Association, European Societies of Dermatology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Centre for Complementary and Integrative Health were referred to, in order to gain crucial information regarding key players in the arthritis therapeutics market. Insights obtained through primary and secondary research are then authenticated with the data triangulation method.

  • Table 1 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027
  • Table 2 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
  • Table 3 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
  • Table 4 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
  • Table 5 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017–2027
  • Table 6 : North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027
  • Table 7 : North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027
  • Table 8 : North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration,
  • Table 9 : North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
  • Table 10 : North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017–2027
  • Table 11 : Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027
  • Table 12 : Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027
  • Table 13 : Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
  • Table 14 : Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
  • Table 15 : Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027
  • Table 16 : Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027
  • Table 17 : Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
  • Table 18 : Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
  • Table 19 : Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
  • Table 20 : Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027
  • Table 21 : Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027
  • Table 22 : Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027
  • Table 23 : Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
  • Table 24 : Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
  • Table 25 : Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027
  • Table 26 : Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027
  • Table 27 : Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027
  • Table 28 : Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
  • Table 29 : Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
  • Table 30 : Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027
  • Figure 1 : Global Arthritis Therapeutics Market Snapshot
  • Figure 2 : Global Arthritis Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
  • Figure 3 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, 2017?2027
  • Figure 4 : Global Arthritis Therapeutics Market Value Share (%), by Type (2018)
  • Figure 5 : Global Arthritis Therapeutics Market Value Share (%), by Route of Administration (2018)
  • Figure 6 : Global Arthritis Therapeutics Market Value Share (%), by Drug Class (2018)
  • Figure 7 : Global Arthritis Therapeutics Market Value Share (%), by Distribution Channel (2018)
  • Figure 8 : Global Arthritis Therapeutics Market Value Share (%), by Region (2018)
  • Figure 9 : Global Arthritis Therapeutics Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 10 : Global Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027
  • Figure 11 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Rheumatoid Arthritis, 2017–2027
  • Figure 12 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Osteoarthritis, 2017–2027
  • Figure 13 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Psoriatic Arthritis, 2017–2027
  • Figure 14 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gout, 2017–2027
  • Figure 15 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027
  • Figure 16 : Global Arthritis Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 17 : Global Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027
  • Figure 18 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by TNF Inhibitors, 2017–2027
  • Figure 19 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Interleukin Inhibitors, 2017–2027
  • Figure 20 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NSAIDs, 2017–2027
  • Figure 21 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017–2027
  • Figure 22 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Xanthine Oxidase Inhibitors, 2017–2027
  • Figure 23 : Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027
  • Figure 24 : Global Arthritis Therapeutics Market Value Share(%), by Route of Administration, 2018 and 2027
  • Figure 25 : Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2017–2027
  • Figure 26 : Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Parenteral, 2017–2027
  • Figure 27 : Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2017–2027
  • Figure 28 : Global Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 29 : Global Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 30 : Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017–2027
  • Figure 31 : Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017–2027
  • Figure 32 : Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017–2027
  • Figure 33 : Global Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 34 : Global Arthritis Therapeutics Market Value Share Analysis, by Region 2018 and 2027
  • Figure 35 : Global Arthritis Therapeutics Market Attractiveness, by Region, 2019–2027
  • Figure 36 : North America Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
  • Figure 37 : North America Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 38 : North America Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027
  • Figure 39 : North America Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 40 : North America Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027
  • Figure 41 : North America Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 42 : North America Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 43 : North America Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 44 : North America Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 45 : North America Arthritis Therapeutics Market Value Share (%), By Country/Sub-region , 2018 and 2027
  • Figure 46 : North America Arthritis Therapeutics Market Attractiveness, By Country/Sub-region , 2019–2027
  • Figure 47 : Europe Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
  • Figure 48 : Europe Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 49 : Europe Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027
  • Figure 50 : Europe Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 51 : Europe Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027
  • Figure 52 : Europe Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 53 : Europe Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 54 : Europe Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 55 : Europe Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 56 : Europe Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
  • Figure 57 : Europe Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019–2027
  • Figure 58 : Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
  • Figure 59 : Asia Pacific Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 60 : Asia Pacific Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027
  • Figure 61 : Asia Pacific Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 62 : Asia Pacific Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027
  • Figure 63 : Asia Pacific Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 64 : Asia Pacific Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 65 : Asia Pacific Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 66 : Asia Pacific Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 67 : Asia Pacific Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
  • Figure 68 : Asia Pacific Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019–2027
  • Figure 69 : Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
  • Figure 70 : Latin America Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 71 : Latin America Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027
  • Figure 72 : Latin America Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 73 : Latin America Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027
  • Figure 74 : Latin America Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 75 : Latin America Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 76 : Latin America Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 77 : Latin America Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 78 : Latin America Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
  • Figure 79 : Latin America Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019–2027
  • Figure 80 : Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
  • Figure 81 : Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 82 : Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027
  • Figure 83 : Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 84 : Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027
  • Figure 85 : Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 86 : Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 87 : Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 88 : Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 89 : Middle East & Africa Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report